Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Talpaz

Showing results (291-300 of 350) with videos related to

Pageof 35
Sort By:
Annals of Hematology|August 1, 1993
Interferon in chronic myeloid leukemia. A workshop reportM Griesshammer, R Hehlmann, A Hochhaus, et al.
The Journal of Clinical Investigation|December 1, 1991
Interferon-alpha restores the deficient expression of the cytoadhesion molecule lymphocyte function antigen-3 by chronic myelogenous leukemia progenitor cellsG Upadhyaya, S C Guba, S A Sih, et al.
Blood|September 15, 1990
Interferon affects nuclear proteins in cells of clinically sensitive chronic myelogenous leukemia patientsO M Howard, M Talpaz, H Kantarjian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1991
Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemiaM J Keating, H Kantarjian, S O'Brien, et al.
Leukemia|October 27, 1997
Long-term follow-up results of alpha-interferon-based regimens in patients with late chronic phase chronic myelogenous leukemiaS Sacchi, H M Kantarjian, S O'Brien, et al.
Progress in Clinical and Biological Research|January 1, 1992
Molecular approaches to purging of chronic myelogenous leukemia marrow in autologous transplantationT Yuan, Y Q Zhou, C V Herst, et al.
Bone Marrow Transplantation|May 1, 1996
Results with high-dose chemotherapy and unpurged autologous stem cell transplantation in 73 patients with chronic myelogenous leukemia: the MD Anderson experienceI F Khouri, H M Kantarjian, M Talpaz, et al.
Blood|March 1, 1989
Ras oncogene mutations are rare late stage events in chronic myelogenous leukemiaA LeMaistre, M S Lee, M Talpaz, et al.
Blood|November 1, 1991
Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemiaH M Kantarjian, M Talpaz, K Dhingra, et al.
Leukemia|March 1, 1997
Decitabine studies in chronic and acute myelogenous leukemiaH M Kantarjian, S M O'Brien, E Estey, et al.
Pageof 35

Showing results (291-300 of 350) with videos related to

Sort By:
Pageof 35
Annals of Hematology|August 1, 1993
Interferon in chronic myeloid leukemia. A workshop reportM Griesshammer, R Hehlmann, A Hochhaus, et al.
The Journal of Clinical Investigation|December 1, 1991
Interferon-alpha restores the deficient expression of the cytoadhesion molecule lymphocyte function antigen-3 by chronic myelogenous leukemia progenitor cellsG Upadhyaya, S C Guba, S A Sih, et al.
Blood|September 15, 1990
Interferon affects nuclear proteins in cells of clinically sensitive chronic myelogenous leukemia patientsO M Howard, M Talpaz, H Kantarjian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1991
Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemiaM J Keating, H Kantarjian, S O'Brien, et al.
Leukemia|October 27, 1997
Long-term follow-up results of alpha-interferon-based regimens in patients with late chronic phase chronic myelogenous leukemiaS Sacchi, H M Kantarjian, S O'Brien, et al.
Progress in Clinical and Biological Research|January 1, 1992
Molecular approaches to purging of chronic myelogenous leukemia marrow in autologous transplantationT Yuan, Y Q Zhou, C V Herst, et al.
Bone Marrow Transplantation|May 1, 1996
Results with high-dose chemotherapy and unpurged autologous stem cell transplantation in 73 patients with chronic myelogenous leukemia: the MD Anderson experienceI F Khouri, H M Kantarjian, M Talpaz, et al.
Blood|March 1, 1989
Ras oncogene mutations are rare late stage events in chronic myelogenous leukemiaA LeMaistre, M S Lee, M Talpaz, et al.
Blood|November 1, 1991
Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemiaH M Kantarjian, M Talpaz, K Dhingra, et al.
Leukemia|March 1, 1997
Decitabine studies in chronic and acute myelogenous leukemiaH M Kantarjian, S M O'Brien, E Estey, et al.
Pageof 35